Pembrolizumab in the Treatment of Breast Cancer
- PMID: 35857664
- DOI: 10.1056/NEJMe2207532
Pembrolizumab in the Treatment of Breast Cancer
Comment on
-
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical